Food-effect Study of Weekly Administration of (bi-)Daily Oral Docetaxel (ModraDoc006) in Combination With Ritonavir
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2019
Price : $35 *
At a glance
- Drugs Docetaxel (Primary) ; Ritonavir
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Modra Pharmaceuticals
- 25 Mar 2019 Planned End Date changed from 1 Feb 2019 to 1 Jul 2019.
- 25 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 12 May 2017 Status changed from not yet recruiting to recruiting.